The European Commission has approved the subcutaneous administration route and pharmaceutical form of pembrolizumab (pembrolizumab and berahyaluronidase alfa; Keytruda SC)…
Read More

The European Commission has approved the subcutaneous administration route and pharmaceutical form of pembrolizumab (pembrolizumab and berahyaluronidase alfa; Keytruda SC)…
Read More